| Quentiax SR 200 mg prolonged-release tablets PA1347/045/002 |
Quetiapine |
KRKA, d.d., Novo mesto |
Marketed |
| Quentiax SR 300 mg prolonged-release tablets PA1347/045/003 |
Quetiapine hemifumarate |
KRKA, d.d., Novo mesto |
Marketed |
| Quentiax SR 400 mg prolonged-release tablets PA1347/045/005 |
Quetiapine hemifumarate |
KRKA, d.d., Novo mesto |
Marketed |
| Quentiax SR 50 mg prolonged-release tablets PA1347/045/004 |
Quetiapine |
KRKA, d.d., Novo mesto |
Marketed |
| Quetiapine Krka 100mg Film-coated Tablets PA1347/027/002 |
Quetiapine |
KRKA, d.d., Novo mesto |
Marketed |
| Quetiapine Krka 200mg Film-coated Tablets PA1347/027/003 |
Quetiapine |
KRKA, d.d., Novo mesto |
Marketed |
| Quetiapine Krka 25mg Film-coated Tablets PA1347/027/001 |
Quetiapine |
KRKA, d.d., Novo mesto |
Marketed |
| Quetiapine Krka 300mg Film-coated Tablets PA1347/027/004 |
Quetiapine |
KRKA, d.d., Novo mesto |
Marketed |
| Rabeprazole Krka 10mg Gastro-Resistant Tablets PA1347/030/001 |
Rabeprazole sodium |
KRKA, d.d., Novo mesto |
Marketed |
| Rabeprazole Krka 20mg Gastro-Resistant Tablets PA1347/030/002 |
Rabeprazole sodium |
KRKA, d.d., Novo mesto |
Marketed |
| Ramipril Krka 1.25 mg tablets PA1347/042/001 |
Ramipril |
KRKA, d.d., Novo mesto |
Marketed |
| Ramipril Krka 10 mg tablets PA1347/042/004 |
Ramipril |
KRKA, d.d., Novo mesto |
Marketed |
| Ramipril Krka 2.5 mg tablets PA1347/042/002 |
Ramipril |
KRKA, d.d., Novo mesto |
Marketed |
| Ramipril Krka 5 mg tablets PA1347/042/003 |
Ramipril |
KRKA, d.d., Novo mesto |
Marketed |
| Ranolazine Krka 375 mg prolonged-release tablets PA1347/109/001 |
Ranolazine |
KRKA, d.d., Novo mesto |
Marketed |
| Ranolazine Krka 500 mg prolonged-release tablets PA1347/109/002 |
Ranolazine |
KRKA, d.d., Novo mesto |
Marketed |
| Ranolazine Krka 750 mg prolonged-release tablets PA1347/109/003 |
Ranolazine |
KRKA, d.d., Novo mesto |
Marketed |
| Rasagiline Krka 1 mg tablets PA1347/088/001 |
Rasagiline |
KRKA, d.d., Novo mesto |
Marketed |
| Refixia 1 000 IU powder and solvent for solution for injection EU/1/17/1193/002 |
Nonacog beta pegol |
Novo Nordisk A/S |
— |
| Refixia 2 000 IU powder and solvent for solution for injection EU/1/17/1193/003 |
Nonacog beta pegol |
Novo Nordisk A/S |
— |
| Refixia 3 000 IU powder and solvent for solution for injection EU/1/17/1193/004 |
Nonacog beta pegol |
Novo Nordisk A/S |
— |
| Refixia 500 IU powder and solvent for solution for injection EU/1/17/1193/001 |
Nonacog beta pegol |
Novo Nordisk A/S |
— |
| Repaglinide Krka 0.5 mg tablets EU/1/09/579/1-6 |
Repaglinide |
KRKA, d.d., Novo mesto |
— |
| Repaglinide Krka 1 mg tablets EU/1/09/579/7-12 |
Repaglinide |
KRKA, d.d., Novo mesto |
— |
| Repaglinide Krka 2 mg tablets EU/1/09/579/13-18 |
Repaglinide |
KRKA, d.d., Novo mesto |
— |
| Rivaroxaban Krka 10 mg film-coated tablets PA1347/098/002 |
Rivaroxaban |
KRKA, d.d., Novo mesto |
Marketed |
| Rivaroxaban Krka 15 mg film-coated tablets PA1347/098/003 |
Rivaroxaban |
KRKA, d.d., Novo mesto |
Marketed |
| Rivaroxaban Krka 2.5 mg film-coated tablets PA1347/098/001 |
Rivaroxaban |
KRKA, d.d., Novo mesto |
Not marketed |
| Rivaroxaban Krka 20 mg film-coated tablets PA1347/098/004 |
Rivaroxaban |
KRKA, d.d., Novo mesto |
Marketed |
| Rolpryna SR 2 mg prolonged-release tablets PA1347/012/001 |
Ropinirole hydrochloride |
KRKA, d.d., Novo mesto |
Marketed |
| Rolpryna SR 4 mg prolonged-release tablets PA1347/012/002 |
Ropinirole hydrochloride |
KRKA, d.d., Novo mesto |
Marketed |
| Rolpryna SR 8 mg prolonged-release tablets PA1347/012/003 |
Ropinirole hydrochloride |
KRKA, d.d., Novo mesto |
Marketed |
| Rosuvastatin Krka 10 mg film-coated tablets PA1347/016/002 |
Rosuvastatin |
KRKA, d.d., Novo mesto |
Marketed |
| Rosuvastatin Krka 20 mg film-coated tablets PA1347/016/003 |
Rosuvastatin |
KRKA, d.d., Novo mesto |
Marketed |
| Rosuvastatin Krka 40 mg film-coated tablets PA1347/016/004 |
Rosuvastatin |
KRKA, d.d., Novo mesto |
Marketed |
| Rosuvastatin Krka 5 mg film-coated tablets PA1347/016/001 |
Rosuvastatin |
KRKA, d.d., Novo mesto |
Marketed |
| Rosuvastatin/Ezetimibe KRKA 10 mg/10 mg Film-Coated Tablets PA1347/108/001 |
Rosuvastatin calcium, Ezetimibe |
KRKA, d.d., Novo mesto |
Marketed |
| Rosuvastatin/Ezetimibe KRKA 20 mg/10 mg Film-Coated Tablets PA1347/108/002 |
Rosuvastatin calcium, Ezetimibe |
KRKA, d.d., Novo mesto |
Marketed |
| Rosuvastatin/Ezetimibe Krka 40 mg/10 mg film-coated tablets PA1347/108/003 |
Rosuvastatin calcium, Ezetimibe |
KRKA, d.d., Novo mesto |
Marketed |
| Rybelsus 1.5 mg tablets EU/1/20/1430/016-020 |
Semaglutide |
Novo Nordisk A/S |
— |
| Rybelsus 14 mg tablets EU/1/20/1430/008-010 |
Semaglutide |
Novo Nordisk A/S |
— |
| Rybelsus 25 mg tablets EU/1/20/1430/031-035 |
Semaglutide |
Novo Nordisk A/S |
— |
| Rybelsus 3 mg tablets EU/1/20/1430/001-004 |
Semaglutide |
Novo Nordisk A/S |
— |
| Rybelsus 4 mg tablets EU/1/20/1430/021-025 |
Semaglutide |
Novo Nordisk A/S |
— |
| Rybelsus 50 mg tablets EU/1/20/1430/036-040 |
Semaglutide |
Novo Nordisk A/S |
— |
| Rybelsus 7 mg tablets EU/1/20/1430/005-007 |
Semaglutide |
Novo Nordisk A/S |
— |
| Rybelsus 9 mg tablets EU/1/20/1430/026-030 |
Semaglutide |
Novo Nordisk A/S |
— |
| Ryzodeg 100 units/mL solution for injection EU/1/12/806/1,4,5,7,8 |
Insulin degludec (ideg), Insulin aspart |
Novo Nordisk A/S |
— |
| Sacubitril/Valsartan Krka 24 mg/26 mg film-coated tablets PA1347/119/001 |
Sacubitril sodium, Valsartan disodium |
KRKA, d.d., Novo mesto |
Not marketed |
| Sacubitril/Valsartan Krka 49 mg/51 mg film-coated tablets PA1347/119/002 |
Sacubitril sodium, Valsartan disodium |
KRKA, d.d., Novo mesto |
Not marketed |